Some use peptides for 6-12 months to achieve a specific body composition goal, while those with chronic obesity may require long-term maintenance dosing to prevent metabolic relapse
However, because this medication affects blood sugar levels, its important to be monitored by a healthcare provider
AOD-9604: Direct Lipolysis Theory AOD-9604 is a modified C-terminal fragment of human growth hormone, designed to isolate GH's fat-metabolizing properties: Lipolysis Activation: Theorized to stimulate fat breakdown through beta-3 adrenergic receptor pathways No IGF-1 Stimulation: Unlike full GH, AOD-9604 does not elevate insulin-like growth factor 1 Non-diabetogenic: Does not impair glucose metabolism or insulin sensitivity No Anabolic Effects: Does not promote muscle or organ growth Semaglutide: Central Regulation Theory Semaglutide achieves weight loss through systemic metabolic regulation: Hypothalamic Appetite Control: GLP-1 receptors in the brain reduce hunger and food-seeking behavior Gastric Emptying: Slowed stomach emptying promotes early satiety Insulin Optimization: Glucose-dependent insulin secretion improves metabolic efficiency Reward Pathway Modulation: Reduced hedonic eating and food reward responses The fundamental difference: AOD-9604 attempts to "burn" existing fat directly, while Semaglutide reduces caloric intake through appetite and satiety mechanisms, creating an energy deficit that leads to fat loss
The different names for vitamin B 12 include: Cobalamin : This is the general term for compounds having vitamin B 12 activity
GHK-Cu: Has an affinity to skin cells and acts as a signaling molecule for tissue repair and natural anti-inflammatory responses
Throughout this period, the favorable safety profile remained consistent with no delayed-onset adverse effects or concerning laboratory changes emerging over time
